Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kintz Samuel
PRESIDENT AND CEO at Enliven Therapeutics. Filing since 25 Sep 2023.
CIK 0001967168
Company
Date
Role
Action
Shares
Amount
Of holding
ELVN
Enliven Therapeutics, Inc.
17 Nov 2025
PRESIDENT AND CEO
Sold on a plan
12,500
$272.74K
1.4%
ELVN
Enliven Therapeutics, Inc.
17 Oct 2025
PRESIDENT AND CEO
Sold on a plan
12,500
$266.65K
1.4%
ELVN
Enliven Therapeutics, Inc.
26 Sep 2025
PRESIDENT AND CEO
Sold on a plan
3,700
$74.23K
0.4%
ELVN
Enliven Therapeutics, Inc.
23 Sep 2025
PRESIDENT AND CEO
Sold on a plan
2,800
$56.08K
0.3%
ELVN
Enliven Therapeutics, Inc.
19 Sep 2025
PRESIDENT AND CEO
Sold on a plan
1,000
$20.25K
0.1%
ELVN
Enliven Therapeutics, Inc.
17 Sep 2025
PRESIDENT AND CEO
Sold on a plan
5,000
$95.47K
0.5%
ELVN
Enliven Therapeutics, Inc.
19 Aug 2025
PRESIDENT AND CEO
Sold on a plan
590
$11.80K
0.1%
ELVN
Enliven Therapeutics, Inc.
18 Aug 2025
PRESIDENT AND CEO
Sold on a plan
10,393
$208.11K
1.1%
ELVN
Enliven Therapeutics, Inc.
17 Jul 2025
PRESIDENT AND CEO
Sold on a plan
12,500
$281.52K
1.3%
ELVN
Enliven Therapeutics, Inc.
17 Jun 2025
PRESIDENT AND CEO
Sold on a plan
12,500
$277.29K
1.3%
ELVN
Enliven Therapeutics, Inc.
3 Jun 2025
PRESIDENT AND CEO
Sold on a plan
7,500
$150.35K
0.8%
ELVN
Enliven Therapeutics, Inc.
19 May 2025
PRESIDENT AND CEO
Sold on a plan
5,000
$82.45K
0.5%
ELVN
Enliven Therapeutics, Inc.
2 May 2025
PRESIDENT AND CEO
Sold on a plan
2,170
$43.41K
0.2%
ELVN
Enliven Therapeutics, Inc.
1 May 2025
PRESIDENT AND CEO
Sold on a plan
5,330
$107.01K
0.5%
ELVN
Enliven Therapeutics, Inc.
17 Apr 2025
PRESIDENT AND CEO
Sold on a plan
5,000
$82.10K
0.5%
ELVN
Enliven Therapeutics, Inc.
17 Mar 2025
PRESIDENT AND CEO
Sold on a plan
12,500
$260.32K
1.2%
ELVN
Enliven Therapeutics, Inc.
18 Oct 2024
PRESIDENT AND CEO
Sold on a plan
924
$27.72K
0.1%
ELVN
Enliven Therapeutics, Inc.
9 Oct 2024
PRESIDENT AND CEO
Sold on a plan
16,710
$470.41K
1.6%
ELVN
Enliven Therapeutics, Inc.
8 Oct 2024
PRESIDENT AND CEO
Sold on a plan
13,267
$370.93K
1.3%
ELVN
Enliven Therapeutics, Inc.
7 Oct 2024
PRESIDENT AND CEO
Sold on a plan
2,730
$75.08K
0.3%
ELVN
Enliven Therapeutics, Inc.
4 Oct 2024
PRESIDENT AND CEO
Sold on a plan
12,206
$335.79K
1.2%
ELVN
Enliven Therapeutics, Inc.
1 Oct 2024
PRESIDENT AND CEO
Sold on a plan
526
$14.48K
0.1%
ELVN
Enliven Therapeutics, Inc.
26 Aug 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$274.72K
1.1%
ELVN
Enliven Therapeutics, Inc.
31 Jul 2024
PRESIDENT AND CEO
Sold on a plan
2,270
$62.56K
0.2%
ELVN
Enliven Therapeutics, Inc.
25 Jul 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$299.07K
1.1%
ELVN
Enliven Therapeutics, Inc.
25 Jun 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$259.90K
1.1%
ELVN
Enliven Therapeutics, Inc.
28 May 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$278.21K
100%
ELVN
Enliven Therapeutics, Inc.
25 Apr 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$202.70K
100%
ELVN
Enliven Therapeutics, Inc.
11 Apr 2024
PRESIDENT AND CEO
Sold on a plan
47,709
$1.19M
100%
ELVN
Enliven Therapeutics, Inc.
25 Mar 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$210.66K
100%
ELVN
Enliven Therapeutics, Inc.
26 Feb 2024
PRESIDENT AND CEO
Sold on a plan
12,000
$202.65K
100%
ELVN
Enliven Therapeutics, Inc.
25 Jan 2024
President and CEO
Sold on a plan
12,000
$188.23K
100%
ELVN
Enliven Therapeutics, Inc.
26 Dec 2023
President and CEO
Sold on a plan
12,000
$175.71K
100%
ELVN
Enliven Therapeutics, Inc.
22 Dec 2023
President and CEO
Sold at will
8,175
$106.66K
100%
ELVN
Enliven Therapeutics, Inc.
21 Dec 2023
President and CEO
Sold at will
20
$260.00
100%
ELVN
Enliven Therapeutics, Inc.
20 Dec 2023
President and CEO
Sold on a plan
7,779
$101.24K
100%
ELVN
Enliven Therapeutics, Inc.
3 Nov 2023
President and CEO
Sold on a plan
8,026
$105.00K
100%
ELVN
Enliven Therapeutics, Inc.
25 Sep 2023
President and CEO
Sold on a plan
12,000
$165.69K
100%
38 decisions on file.
